{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:55:19Z","timestamp":1787028919856,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background\/Objectives: Oppositional defiant disorder (ODD) and conduct disorder (CD) are important behavior disorders in children and adolescents, often linked with long-term psychosocial problems. Antipsychotics are frequently prescribed to manage severe symptoms and improve behavior, but their efficacy in this population is still unclear and a lot of physicians are remittent in prescribing them. This systematic review aims to assess the effectiveness of antipsychotic treatment in reducing symptoms associated with ODD and CD in children and adolescents. Methods: Studies that investigated how effective antipsychotic treatments are for children and teens diagnosed with oppositional defiant disorder (ODD) and conduct disorder (CD) were reviewed. Only studies that met a few main criteria were included: participants were between 5 and 18 years old with an ODD or CD diagnosis; the treatment could be any type of antipsychotic, whether typical or atypical; the accepted study designs were randomized controlled trials (RCTs), cohort studies, systematic reviews with meta-analysis, or observational studies. The outcomes of interest were reductions in aggressive or defiant behaviors, improvements in social functioning, and the occurrence of any adverse effects from the medications. There was no restriction on the language of publication, and studies published from 2000 to 2024 were considered. Studies that focused only on non-antipsychotic drugs or behavioral therapies, as well as case reports, expert opinions, and non-peer-reviewed articles did not meet the inclusion criteria. Results: The review consisted of 13 studies. The results suggest that some antipsychotic drugs\u2014especially atypical antipsychotics\u2014can substantially reduce aggressive and defiant behavior in children and adolescents who have oppositional defiant disorder (ODD) or conduct disorder (CD). Common side effects of these medications include weight gain, sedation, and metabolic problems. Conclusions: Although adverse effects are a concern, the potential of these medications to manage disruptive behaviors should not be overlooked. When used in combination with behavioral therapy and other forms of treatment, antipsychotics can markedly improve the outcomes of these very difficult-to-treat patients. Clinicians who treat these patients need to consider antipsychotics as a serious option. If they do not, they are denying their patients medication that could greatly benefit them.<\/jats:p>","DOI":"10.3390\/medicines12030015","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:42:34Z","timestamp":1750664554000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Breaking the Stigma: A Systematic Review of Antipsychotic Efficacy in Children and Adolescents with Behavioral Disorders"],"prefix":"10.3390","volume":"12","author":[{"given":"Nuno","family":"Sanfins","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2342-0107","authenticated-orcid":false,"given":"Pedro","family":"Andrade","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-4443","authenticated-orcid":false,"given":"Jacinto","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Hospital Central Vila do Conde, Grupo Trofa Sa\u00fade, 4480-565 Vila do Conde, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-019-0095-y","article-title":"Conduct disorder","volume":"5","author":"Fairchild","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/00004583-200012000-00007","article-title":"Oppositional defiant and conduct disorder: A review of the past 10 years, part I","volume":"39","author":"Loeber","year":"2000","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archpsyc.62.1.66","article-title":"Subthreshold depression in adolescence and mental health outcomes in adulthood","volume":"62","author":"Fergusson","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1469-7610.1997.tb01851.x","article-title":"Practitioner review: Psychosocial treatments for conduct disorder in children","volume":"38","author":"Kazdin","year":"1997","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_5","first-page":"27","article-title":"Pharmacotherapy of aggression in children and adolescents: Efficacy and effect size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"J. Can. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371506000203","article-title":"The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Meta-Analysis. Part 2: Antipsychotics and Traditional Mood Stabilizers","volume":"60","author":"Pringsheim","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"ref_7","first-page":"9","article-title":"Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents","volume":"69","author":"Findling","year":"2008","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.9758\/cpn.2019.17.1.43","article-title":"Clozapine in the Treatment of Aggression in Conduct Disorder in Children and Adolescents: A Randomized, Double-blind, Controlled Trial","volume":"17","author":"Esquivel","year":"2019","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_10","first-page":"CD008559","article-title":"Atypical antipsychotics for disruptive behaviour disorders in children and youths","volume":"8","author":"Loy","year":"2017","journal-title":"Cochrane. Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaac.2016.03.014","article-title":"Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial","volume":"55","author":"Gadow","year":"2016","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","article-title":"A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct Disorder","volume":"39","author":"Findling","year":"2000","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/appi.ajp.163.3.402","article-title":"A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents with Disruptive Behavior Disorders","volume":"163","author":"Reyes","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eurpsy.2004.11.010","article-title":"Olanzapine treatment in adolescents with severe conduct disorder","volume":"21","author":"Masi","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.chi.0000219832.23849.31","article-title":"Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder","volume":"45","author":"Findling","year":"2006","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/cap.2006.0012","article-title":"Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct\/oppositional-defiant disorder, and aggression: A prospective, open-label study","volume":"17","author":"Kronenberger","year":"2007","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/cap.2008.0111","article-title":"An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder","volume":"19","author":"Findling","year":"2009","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: Effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1080\/14656566.2018.1509069","article-title":"Using antipsychotics for behavioral problems in children","volume":"19","author":"Shafiq","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.psychres.2016.12.010","article-title":"Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed\u2014Results from a randomized, double-blind, placebo-controlled clinical trial","volume":"251","author":"Jahangard","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/cap.2006.0007","article-title":"Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder","volume":"18","author":"Connor","year":"2008","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1469-7610.00424","article-title":"Comorbidity","volume":"40","author":"Angold","year":"1999","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1469-7610.2004.00250.x","article-title":"Conduct disorder and oppositional defiant disorder in a national sample: Developmental epidemiology","volume":"45","author":"Maughan","year":"2004","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_25","first-page":"50","article-title":"Comorbidity of attention-deficit\/hyperactivity disorder with psychiatric disorder: An overview","volume":"59","author":"Pliszka","year":"1998","journal-title":"J. Clin. Psychiatry."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-7610.2007.01823.x","article-title":"Research review: DSM-V conduct disorder: Research needs for an evidence base","volume":"49","author":"Moffitt","year":"2008","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","article-title":"ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups","volume":"40","author":"Jensen","year":"2001","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1469-7610.2005.01456.x","article-title":"The stigmatization of mental illness in children and parents: Developmental issues, family concerns, and research needs","volume":"46","author":"Hinshaw","year":"2005","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2105\/AJPH.2012.301147","article-title":"The \u201cBackbone\u201d of Stigma: Identifying the Global Core of Public Prejudice Associated with Mental Illness","volume":"103","author":"Pescosolido","year":"2013","journal-title":"Am. J. Public Health"}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/12\/3\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:59Z","timestamp":1760032619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/12\/3\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicines12030015"],"URL":"https:\/\/doi.org\/10.3390\/medicines12030015","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}